AAAAAA

   
Results: 1-9 |
Results: 9
ANTIPLATELET EFFECTS OF R,S-(MESO)-ALPHA, '-BIS[3-(N,N-DIETHYLCARBAMOYL)PIPERIDINO]-P-XYLENE EX-VIVO IN THE DOG AND IN-VIVO IN THE MOUSE
Authors: HAN GZ BANNERMAN D HANDA RK DILLINGHAM EO LAWRENCE WH GOLLAMUDI R
Citation: Gz. Han et al., ANTIPLATELET EFFECTS OF R,S-(MESO)-ALPHA, '-BIS[3-(N,N-DIETHYLCARBAMOYL)PIPERIDINO]-P-XYLENE EX-VIVO IN THE DOG AND IN-VIVO IN THE MOUSE, General pharmacology, 28(4), 1997, pp. 617-621
INHIBITION OF PAF-INDUCED HUMAN PLATELET-AGGREGATION BY ANTITHROMBOTIC NIPECOTAMIDES
Authors: HERRON D DILLINGHAM EO LYMAN BA ZHENG X BOND SE SALGIA SR GOLLAMUDI R
Citation: D. Herron et al., INHIBITION OF PAF-INDUCED HUMAN PLATELET-AGGREGATION BY ANTITHROMBOTIC NIPECOTAMIDES, Prostaglandins, leukotrienes and essential fatty acids, 52(5), 1995, pp. 309-318
ANTITHROMBOTIC NIPECOTAMIDE INCREASES CYCLIC-AMP LEVELS AND INHIBITS PROTEIN-PHOSPHORYLATION IN HUMAN PLATELETS
Authors: HANDA RK DILLINGHAM EO GOLLAMUDI R
Citation: Rk. Handa et al., ANTITHROMBOTIC NIPECOTAMIDE INCREASES CYCLIC-AMP LEVELS AND INHIBITS PROTEIN-PHOSPHORYLATION IN HUMAN PLATELETS, Life sciences, 57(10), 1995, pp. 983-988
DESIGN AND SYNTHESIS OF PIPERIDINE-3-CARBOXAMIDES AS HUMAN PLATELET-AGGREGATION INHIBITORS (VOL 38, PG 181, 1995)
Authors: ZHENG XZ SALGIA SR THOMPSON WB DILLINGHAM EO BOND SE FENG ZX PRASAD KR GOLLAMUDI R
Citation: Xz. Zheng et al., DESIGN AND SYNTHESIS OF PIPERIDINE-3-CARBOXAMIDES AS HUMAN PLATELET-AGGREGATION INHIBITORS (VOL 38, PG 181, 1995), Journal of medicinal chemistry, 38(8), 1995, pp. 1416-1416
DESIGN AND SYNTHESIS OF PIPERIDINE-3-CARBOXAMIDES AS HUMAN PLATELET-AGGREGATION INHIBITORS
Authors: ZHENG XZ SALGIA SR THOMPSON WB DILLINGHAM EO BOND SE FENG ZX PRASAD KR GOLLAMUDI R
Citation: Xz. Zheng et al., DESIGN AND SYNTHESIS OF PIPERIDINE-3-CARBOXAMIDES AS HUMAN PLATELET-AGGREGATION INHIBITORS, Journal of medicinal chemistry, 38(1), 1995, pp. 180-188
INHIBITION OF AGONIST-INDUCED RISE IN PLATELET CA2+ BY ANTITHROMBOTICNIPECOTAMIDES
Authors: GOLLAMUDI R DILLINGHAM EO BOND SE
Citation: R. Gollamudi et al., INHIBITION OF AGONIST-INDUCED RISE IN PLATELET CA2+ BY ANTITHROMBOTICNIPECOTAMIDES, Blood coagulation & fibrinolysis, 5(3), 1994, pp. 375-383
SYNERGISTIC ANTIPLATELET EFFECTS OF A NIPECOTAMIDE A-1C AND LOW-DOSE ASPIRIN
Authors: HAN GZ BOND SE LAWRENCE WH DILLINGHAM EO ZHENG XZ GOLLAMUDI R
Citation: Gz. Han et al., SYNERGISTIC ANTIPLATELET EFFECTS OF A NIPECOTAMIDE A-1C AND LOW-DOSE ASPIRIN, General pharmacology, 25(7), 1994, pp. 1373-1379
EVIDENCE FOR MULTIPLE SITES OF INHIBITION BY NOVEL ANTIPLATELET NIPECOTAMIDES
Authors: GOLLAMUDI R DILLINGHAM EO BOND SE
Citation: R. Gollamudi et al., EVIDENCE FOR MULTIPLE SITES OF INHIBITION BY NOVEL ANTIPLATELET NIPECOTAMIDES, Thrombosis and haemostasis, 69(6), 1993, pp. 1322-1322
ANTITHROMBOTIC NIPECOTAMIDES AS PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONISTS
Authors: HERRON D LYMAN BA DILLINGHAM EO BOND SE GOLLAMUDI R
Citation: D. Herron et al., ANTITHROMBOTIC NIPECOTAMIDES AS PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONISTS, Blood, 82(10), 1993, pp. 10000284-10000284
Risultati: 1-9 |